Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings

What is it about?

The use of multimodal testing is recommended as the optimal Chemotherapy-Induced Peripheral Neurotoxicity assessment strategy, employing objective Nerve Conduction Studies and other specialized techniques together with subjective Patient Reported Outcome measures to reveal the full extent of CIPN abnormalities as well as to provide precise quantification of neuroprotection in clinical trials.

Featured Image